CoChat

Genetic risk for Alzheimer’s disease is concentrated in specific macrophage and microglial transcriptional networks

Open access

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Genome-wide association studies of Alzheimer's disease (AD) have identified a number of significant risk loci, the majority of which lie in non-coding regions of the genome. The lack of causal alleles and considerable polygenicity remains a significant barrier to translation into mechanistic understanding. This includes identifying causal variants and the cell/tissue types in which they operate. A fuller understanding of the cell types and transcriptional networks involved in AD genetic risk mechanisms will provide important insights into pathogenesis. METHODS: We assessed the significance of the overlap between genome-wide significant AD risk variants and sites of open chromatin from data sets representing diverse tissue types. We then focussed on macrophages and microglia to investigate the role of open chromatin sites containing motifs for specific transcription factors. Partitioned heritability using LDscore regression was used to investigate the contribution of specific macrophage and microglia transcription factor motif-containing open chromatin sites to the heritability of AD. RESULTS: ) and microglia (z score = 4.34, corrected P = 0.011). In both macrophages and microglia, AD risk variants are enriched at a subset of open chromatin sites that contain DNA binding motifs for specific transcription factors, e.g. SPI1 and MEF2. Genetic variation at many of these motif-containing sites also mediate a substantial proportion of AD heritability, with SPI1-containing sites capturing the majority of the common variant SNP-chip heritability (microglia enrichment = 16.28, corrected enrichment P = 0.0044). CONCLUSIONS: AD risk alleles plausibly operate in immune cells, including microglia, and are concentrated in specific transcriptional networks. Combined with primary genetic association results, the SPI1 and MEF2 transcriptional networks appear central to AD risk mechanisms. Investigation of transcription factors targeting AD risk SNP associated regulatory elements could provide powerful insights into the molecular processes affected by AD polygenic risk. More broadly, our findings support a model of polygenic disease risk that arises from variants located in specific transcriptional networks.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13073-018-0523-8

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Overlap between genome-wide significant AD risk variants and DNase hypersensitivity sites from 38 tissues profiled by the Roadmap Epigenomics Project. AD risk variants and 10,000 sets of matched SNPs were intersected with DNase hypersensitivity sites. Z scores were calculated for the AD risk variants set for each tissue type. The x-axis is the z score and the y-axis the tissue types. Box plots indicate the distribution of overlap from the 10,000 background matched SNP sets. Tissue have been coded as blood (green), brain (blue) and other (orange). Red circles are the z scores for the AD risk variants set. P values were calculated from the observed overlap of the 10,000 background matched SNP sets. P values are corrected using the method described by Benjamini and Hochberg [24]. AD Alzheimer’s disease, SNP single nucleotide polymorphism. ***P < 0.005, **P < 0.01
Fig. 1 Overlap between genome-wide significant AD risk variants and DNase hypersensitivity sites from 38 tissues profiled by the Roadmap Epigenomics Project. AD risk variants and 10,000 sets of matched SNPs were intersected with DNase hypersensitivity sites. Z scores were calculated for the AD risk variants set for each tissue type. The x-axis is the z score and the y-axis the tissue types. Box plots indicate the distribution of overlap from the 10,000 background matched SNP sets. Tissue have been coded as blood (green), brain (blue) and other (orange). Red circles are the z scores for the AD risk variants set. P values were calculated from the observed overlap of the 10,000 background matched SNP sets. P values are corrected using the method described by Benjamini and Hochberg [24]. AD Alzheimer’s disease, SNP single nucleotide polymorphism. ***P < 0.005, **P < 0.01CC BY · PubMed Central
Fig. 2 Overlap between genome-wide significant AD risk variants and open chromatin sites identified in monocyte, macrophage and microglia samples. AD risk variants and 10,000 sets of matched SNPs were intersected with open chromatin regions. z scores were calculated for the AD risk variants set for each tissue type. The x-axis is the z score and the y-axis the cell type. Box plots indicate the distribution of overlap from the 10,000 background matched SNP sets. Red circles are the z scores for the AD risk variants set. P values were calculated from the observed overlap of the 10,000 background matched SNP sets. P values have been corrected for 37 tests. AD Alzheimer’s disease, SNP single-nucleotide polymorphism. ***P < 0.005, **P < 0.01, *P < 0.05
Fig. 2 Overlap between genome-wide significant AD risk variants and open chromatin sites identified in monocyte, macrophage and microglia samples. AD risk variants and 10,000 sets of matched SNPs were intersected with open chromatin regions. z scores were calculated for the AD risk variants set for each tissue type. The x-axis is the z score and the y-axis the cell type. Box plots indicate the distribution of overlap from the 10,000 background matched SNP sets. Red circles are the z scores for the AD risk variants set. P values were calculated from the observed overlap of the 10,000 background matched SNP sets. P values have been corrected for 37 tests. AD Alzheimer’s disease, SNP single-nucleotide polymorphism. ***P < 0.005, **P < 0.01, *P < 0.05CC BY · PubMed Central
Fig. 3 Overlap between genome-wide significant AD risk variants and open chromatin regions from the consolidated set of (a) macrophage and (b) microglia samples. Grey histogram bars are the distribution of overlap from the 10,000 background matched SNP sets. The vertical black line is the number of overlapping loci from the AD risk variants set. AD Alzheimer’s disease, SNP single-nucleotide polymorphism
Fig. 3 Overlap between genome-wide significant AD risk variants and open chromatin regions from the consolidated set of (a) macrophage and (b) microglia samples. Grey histogram bars are the distribution of overlap from the 10,000 background matched SNP sets. The vertical black line is the number of overlapping loci from the AD risk variants set. AD Alzheimer’s disease, SNP single-nucleotide polymorphismCC BY · PubMed Central
Fig. 4 Overlap between genome-wide significant AD risk variants and transcription factor motif-containing open chromatin sites from the consolidated macrophage (a) and microglia (b) data. AD risk variants and 10,000 sets of matched SNPs were intersected with transcription factor motif-containing open chromatin region sets and one no-motif-containing set for each cell type. The x-axis is the z score and the y-axis is the transcription factor motif. Box plots indicate the distribution of overlap from the 10,000 background matched SNP sets. Red circles are the z scores for the AD risk variant set. P values were calculated from the observed overlap of the 10,000 background matched sets. P values have been adjusted within each cell type using the Bonferroni correction for the number of motif sets tested. AD Alzheimer’s disease, SNP single-nucleotide polymorphism. ***P < 0.005, *P < 0.05
Fig. 4 Overlap between genome-wide significant AD risk variants and transcription factor motif-containing open chromatin sites from the consolidated macrophage (a) and microglia (b) data. AD risk variants and 10,000 sets of matched SNPs were intersected with transcription factor motif-containing open chromatin region sets and one no-motif-containing set for each cell type. The x-axis is the z score and the y-axis is the transcription factor motif. Box plots indicate the distribution of overlap from the 10,000 background matched SNP sets. Red circles are the z scores for the AD risk variant set. P values were calculated from the observed overlap of the 10,000 background matched sets. P values have been adjusted within each cell type using the Bonferroni correction for the number of motif sets tested. AD Alzheimer’s disease, SNP single-nucleotide polymorphism. ***P < 0.005, *P < 0.05CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 115

Metadata

Authors
Tansey, K. E., Cameron, D., & Hill, M. J.
Affiliations
  • Cardiff University (GB)
  • UK Dementia Research Institute (GB)
Corresponding author
Hill, Matthew J.
Venue
Genome Medicine
Published
2018-02-26
Volume
10
Issue
1
Pages
14-14
ISSN
1756-994X (ISSN-L)
OpenAlex
W2797937460
Cited by
115
References
34
Citations by year
2026: 6 · 2025: 14 · 2024: 13 · 2023: 15 · 2022: 16 · 2021: 22 · 2020: 14 · 2019: 13 · 2018: 2
FWCI
8.77
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Genome Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Wellcome Trust (FP7/2007–2013, WT105613/Z/14/Z, MR/L010305/1)
  • European Commission (282510, 2007–2013, FP7 2007-2013, FP7/2007)
  • Cardiff University (MR/L010305/1)
  • Medical Research Council (FP7/20072013, MR/L010305/1)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, genetic susceptibility loci, macrophages, microglia, open chromatin, transcription factor binding motifs, PU.1, MEF2, polygenic heritability, causal variants, non-coding regulatory elements, immune cells
MeSH terms
Alzheimer Disease, Chromatin, Deoxyribonucleases, Humans, Macrophages, Monocytes, Organ Specificity, Risk Factors, Transcription Factors, Transcription, Genetic, Microglia, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Inheritance Patterns, Gene Regulatory Networks, Nucleotide Motifs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic risk for Alzheimer’s disease is concentrated in specific macrophage and microglial transcriptional networks. https://app.cochat.ai/papers/10.1186/s13073-018-0523-8
The paper
Tansey, K. E., Cameron, D., & Hill, M. J. (2018). Genetic risk for Alzheimer’s disease is concentrated in specific macrophage and microglial transcriptional networks. Genome Medicine. https://doi.org/10.1186/s13073-018-0523-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.